Subject has an active infection Active infection Has an active systemic infection Active infection Uncontrolled intercurrent active infection; controlled infection on long term suppressive or maintenance therapy is permissible Active serious infection Active infection Evidence of active infection Active infection =< days prior to study entry Patients with active infection Recent (< weeks) active, documented, cervical infection Patients with active infection DONOR: Evidence of active infection No active or uncontrollable infection. Active infection Active or incompletely treated local infection at the planned treatment site(s) and/or systemic infection Active uncontrolled infection or severe systemic infection (enrollment is possible after control of infection). Active infection, including any active viral infection, =< days prior to registration DONOR: Active infection Patients with active systemic, pulmonary, or pericardial infection Active infection DONOR: Active infection Active infection No active or uncontrollable infection HIV infection, active Hepatitis B or C infection, or active infections requiring oral or intravenous antibiotics or that can cause a severe disease and pose a severe danger to lab personnel working on patients' blood or tissue. If positive test results are not indicative of an active infection, patients can be included. Active infection Active infection =< days prior to registration Active systemic, pulmonary, or pericardial infection Patients with active infection Active infection DONOR: Evidence of active infection Active herpes zoster infection Active infection =< days prior to registration Patients with active infection No active infection Active systemic infection Active infection Active and uncontrolled infection at time of transplantation including active infection with Aspergillus or other mold, or human immunodeficiency virus (HIV) infection Active systemic, pulmonary, or pericardial infection Active infection at time of transplantation (including active infection with Aspergillus or other mold within days) Active infection at time of transplantation (including active infection with aspergillus or other mold within days) Current active serious infection Patients with active systemic, pulmonary, or pericardial infection Serious active infection Active infection. Patients with an active infection Subjects with bacteremia with documented microbiological evidence of another source of infection (eg, osteomyelitis, pneumonia, skin infection, urinary tract infection, joint infection, or abdominal infection) known to be due to the same organism cultured from the blood; Active infection Active infection =< days prior to registration Active infection at time of transplantation (including active infection with Aspergillus or other mold within days) Active infection Patients with active infection are ineligible Active infection =< days prior to registration Active serious infection Active urinary tract infection Patient may have no active uncontrollable systemic infection Active ear/sinus infection Patients with active infection Subjects with an active infection They have active diarhhea. Active infection Active infection Active, unresolved infection Patients are ineligible if they have an active infection Active infection; Infection Patients with an active infection. No active systemic, pulmonary, or pericardial infection Current systemic infection or suspicion of active bacterial infection Active infection Active and uncontrolled infection; patients with an active infection receiving treatment and hemodynamically stable for hours may be entered into the study Patient has evidence of active systemic, pulmonary, or pericardial infection. Active unresolved infection Active, unresolved infection Active dental infection Current evidence of invasive fungal infection (blood or tissue culture); patients with recent fungal infection must have a subsequent negative cultures to be eligible; known HIV (new testing not required) or evidence of active hepatitis B or C infection (with rising transaminase values) Active serious infection Evidence of an active pulmonary, gastrointestinal, genitourinary, or other serious infection at time of enrollment Active infection Known active infection, or major episode of infection within week prior to the start of Cycle Serious active infection or gastrointestinal disease Active infection\r\n* Active infection includes patients with positive blood cultures No active infection active urinary tract infection; Active systemic infection Other active disease including but not limited to ulceration of the upper gastrointestinal tract, autoimmune disease, HIV infection, active HBV and HCV infection. Active and uncontrolled infection at time of transplantation including active infection with Aspergillus or other mold, or human immunodeficiency virus (HIV) infection Active infection Active systemic infection Any evidence of serious active infection. Known active systemic infection (Grade ?). Active, clinically serious infection greater than CTCAE grade . Patients may be eligible upon resolution of the infection. Acute, active infection within days of enrollment Patients with active lung infection or active pulmonary edema Known active meningeal infection Active serious infection (pulmonary infiltrates or lesions are allowed only after the appropriate diagnostic testing is negative for infection or appropriate therapy was initiated for probable infection) Concurrent, acute, active infection, or treatment for infection, other than oral thrush or genital herpes, within days of enrollment Active infection Active uncontrolled infection at time of enrollment or documented fungal infection within months No active infection Active infection including cytomegalovirus Other significant active infection. Active urinary tract infection Infection:\r\n* Local infection at the puncture site\r\n* Systemic infection, osteomyelitis, discitis Active infection Concurrent active infection Patients with active infection at time of biopsy No active infection Other significant active infection. Active infection. Known active infection. Infection Active infection Patients should not have any clinical evidence of an active infection at the time of enrollment Patients with active pulmonary or pericardial infection Known active infection Evidence of active infection Infection Infection A serious active infection (> grade ) within days of enrollment Currently active infection Active systemic, pulmonary, or pericardial infection Documented or suspected infection Active infection Serious active infection at the time of pre-study screening. Active infection Active infection with hepatitis A, B, or C; active infection is defined as serologic positivity and elevated liver function tests Active infection Have an active urinary tract infection (UTI), Active lung infection EXCLUSION - STUDY : Active infection Patients with documented infection at time of enrollment Active Infection Active cutaneous infection or inflammation Patients must not have an active infection Active systemic infection Active infection at time of transplantation (including active infection with aspergillus or other mold within days) Active infection. Known human immunodeficiency virus infection, unless well controlled. Patients who are on an adequate antiviral regimen with no evidence of active infection are considered well controlled. Clinically active infection; an active infection may alter the biodistribution of F-FLT Evidence of active infection within days of study enrollment No active skin infection Patient has systemic infection or evidence of any surgical site infection (superficial or organ space), including active urinary tract infection Recognized concurrent active infection Active infection Infection is a common feature of AML; patients with active infection are permitted to enroll provided that the infection is controlled; patients with uncontrolled infection shall not be enrolled until infection is treated and brought under control Active infection Patients with active systemic, pulmonary, or pericardial infection Patients that have recognized concurrent active infection Active infection Patient has systemic infection or evidence of any surgical site infection (superficial or organ space), including active urinary tract infection Active infection